CHRU de Lille — Lille

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of CHRU de Lille, compiled from the ClinicalTrials.gov public registry.

518

Registered studies

111

Active

Recruiting now

303

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed/Refractory Follicular Lymphoma · Prostate Cancer · Multiple Myeloma · Relapsed/Refractory Peripheral T-Cell Lymphoma

Recently updated registry entries

NCT03531099 — Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of… (Active Not Recruiting)
NCT07209852 — Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area… (Recruiting)
NCT06476184 — Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.